FeesSafety
Pluang+

AMG TimesSquare Small Cap Growth Fund beats Russell 2000 Growth Index in Q3 2026 with strong sector performance.

Market News
15 Nov 2026, 19:01 WIB
Seeking Alpha
View Source
Bullish
AMG TimesSquare Small Cap Growth Fund beats Russell 2000 Growth Index in Q3 2026 with strong sector performance.

In Q3 2026, AMG TimesSquare Small Cap Growth Fund outperformed the Russell 2000® Growth Index, driven by strong holdings in Information Technology, Financials, and Consumer Staples sectors. The fund's success was attributed to company-specific fundamentals such as solid results, business momentum, and strategic acquisitions. This performance highlights the fund's focus on quality growth stocks and effective sector positioning, benefiting investors seeking growth in small-cap equities.

AMG TimesSquare Small Cap Growth Fund's Q3 2026 activity provides context for readers following small-cap growth trends. For readers following Financials-sector US stocks on Pluang, here is the market snapshot as of Nov 16, 2026 00:01 WIB: Of 142 priced Financials stocks, 102 rose and 36 fell today. Notable movers include HOOD (Robinhood Markets, Inc.) at USD 77.86 with a 1-day change of -4.29% and a typical hold time of 78 days, GPN (Global Payments Inc) at USD 91.90 with a 1-day change of +4.21% and a typical hold time of 49 days, and PSEC (Prospect Capital Corporation) at USD 1.46 with a 1-day change of +3.91% and a typical hold time of 80 days.

More News

Schwab US Dividend Equity ETF rallies 10% on strong earnings and dividend inflows, with 8% upside potential.

Schwab US Dividend Equity ETF rallies 10% on strong earnings and dividend inflows, with 8% upside potential.

The Schwab US Dividend Equity ETF (SCHD) has rallied about 10% since early October, supported by stronger earnings from key holdings like Texas Instruments and UnitedHealth, as well as inflows into dividend-focused funds. SCHD trades at roughly 18.6 ...

Market News
Bullish
5 hours ago
Helus Pharma to reveal Phase 3 trial results for depression drug HLP003 on Nov 16, 2026

Helus Pharma to reveal Phase 3 trial results for depression drug HLP003 on Nov 16, 2026

Helus Pharma will present topline results from its Phase 3 APPROACH study evaluating HLP003 as an adjunctive treatment for major depressive disorder on November 16, 2026. This drug has received Breakthrough Therapy Designation from the FDA, highlight...

Market News
Neutral
5 hours ago
Eaton Vance ETG fund hikes monthly payout 23.7%, trading at 11%+ discount to NAV

Eaton Vance ETG fund hikes monthly payout 23.7%, trading at 11%+ discount to NAV

Eaton Vance Tax-Advantaged Global Dividend Income Fund (ETG) raised its monthly distribution by 23.7%, marking its highest payout since inception. Despite this increase and strong long-term returns, ETG shares trade at a significant discount of over ...

Market News
Bullish
5 hours ago
Treasury Secretary demands major changes at Nvidia amid CEO resignation and export control concerns.

Treasury Secretary demands major changes at Nvidia amid CEO resignation and export control concerns.

U.S. Treasury Secretary Scott Bessent called for a major overhaul at Nvidia following CEO Jensen Huang's resignation amid allegations of illicit chip sales to China. Bessent urged the company to hire an external CEO and suggested scrutiny of other ex...

Market News
Bearish
5 hours ago
Bitcoin drops to $62,081, lowest since July, amid $1.91B ETF outflows and wider crypto selloff

Bitcoin drops to $62,081, lowest since July, amid $1.91B ETF outflows and wider crypto selloff

Bitcoin fell to $62,081 on Nov. 15, its lowest since mid-July, driven by a weekend selloff and $1.91 billion in net outflows from US spot Bitcoin ETFs over seven days. The decline extends across major cryptocurrencies, with Ether and Solana also drop...

Market News
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App